Company news

Sareum Holdings plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AGM Update

December 7, 2021

Notice of AGM

November 19, 2021

Sareum: Final Results for Year Ended 30 June 2021

October 25, 2021

Correction - Notice of Results

October 21, 2021

US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor

October 7, 2021

Reference to SRA737 Timeline at Cantor Conference

September 29, 2021

Trading Statement

August 19, 2021

Subscription to raise £1,000,000

August 9, 2021

SRA737 update

August 6, 2021

US Patent Notice of Allowance for SDC-1802

July 30, 2021

Exercise of Warrants and Total Voting Rights

July 14, 2021

Covid-19 Research Project Results

July 1, 2021

Sareum to Present at BioTrinity 2021 Conference

June 21, 2021

Subscription to raise £1,470,000

June 15, 2021

Subscription to raise £900,000

June 1, 2021

Exercise of Options and Total Voting Rights

May 13, 2021

Sareum Holdings (SAR): Treading the TYK2 trail

May 5, 2021

Research Update

March 25, 2021

Interim Results Extension

March 25, 2021

Sareum Notes New UK Government Covid-19 Initiative

February 16, 2021

Sareum to Present at the LSX World Congress 2021

February 1, 2021

Sareum to Participate in the Edison Open House

January 26, 2021

Update re: FLT3+Aurora Kinase Inhibitor Programme

January 8, 2021

US Patent Grant for TYK2/JAK1 Anticancer Candidate

January 7, 2021

Nature article highlights role of TYK2 in Covid-19

December 14, 2020

Covid-19 Research Grant Confirmed

December 3, 2020

Update on SRA737 Licensing Agreement

November 12, 2020

Notification of Grant Award for Covid-19 Research

October 27, 2020

Full Year Results Investor Presentation

October 13, 2020

Final Results

October 13, 2020

US Patent Allowance: SDC-1802 TYK2/JAK1 Inhibitor

October 8, 2020

Details of Investor Presentation

August 12, 2020

Update on Deferred Salaries and Issue of Equity

July 1, 2020

Successful Fundraising

June 3, 2020

PrimaryBid.com Offer

June 2, 2020

Placing to raise £718,500

June 2, 2020

Sareum to Present at BIO Digital 2020

May 27, 2020

BioTrinity Presentation Available Online

May 1, 2020

Company Presentation at BioTrinity

April 28, 2020

Global Licensing of FL3+Aurora Programme

March 26, 2020

Publication: new SRA737 combinations in cancer

March 12, 2020

Sareum notes Sierra Oncology Q3 2019 results

November 5, 2019

Research Update - SDC-1802 anti-cancer poster

October 30, 2019

Research Update - AACR-NCI-EORTC abstract

October 17, 2019

Notice of Full Year Results

October 7, 2019

Research Update - TYK2/JAK1 cancer programme

September 27, 2019

Change of Adviser

August 16, 2019

Sareum notes Sierra Q2 results

August 8, 2019

Additional disclosure concerning Michael Owen

July 29, 2019

Additional Funds Raised

June 28, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 13 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.